Effects of propranolol or paracetamol on lidocaine concentrations in serum and tissues

Journal of Oral and Maxillofacial Surgery

Volumn 61, Issue 5, 2003, Pages 604-607

  Saranteas, Theodosios ^a   Mourouzis, Costas ^a,b,c   Koumoura, Fanny ^b   Tesseromatis, Christina ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON 14; LIDOCAINE; LOCAL ANESTHETIC AGENT; METOPROLOL; PARACETAMOL; PINDOLOL; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG PROTEIN BINDING; MALE; MASSETER MUSCLE; NONHUMAN; RAT;

EID: 0038416052     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2003.50090     Document Type: Article

References (30)

1. Katzung GB: Adrenoceptor blockers, in Katzung GB, Trevor A, (eds): The Pharmacology. Norwalk, CT, Appleton & Lange, 1995, p 78
2. Stoetling KR: Alpha and beta adrenergic receptor antagonists, in Stoetling KR (ed): Pharmacology and Physiology in Anesthetic Practice. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, p 290
3. Fitzerald JD: Do partial agonist beta-blockers have improved clinical utility? Cardiovasc Drugs Ther 7:303, 1993
4. Murray KT, Reilly C, Koshakji RP, et al: Supression of ventricular arrythmias in man by propranolol in dependent of beta-adrenergic receptor blockade. J Clin Invest 85:836, 1990
5. Marshall PJ, Kulmacz RJ, Lands WE: Constrains on prostaglandin biosynthesis in tissues. J Biol Chem 262:3510, 1987
6. Butterworth JF, Strichartz GR: Molecular mechanisms of local anesthesia: A review. Anesthesiology 86:722, 1990
7. Scott DB, Jebson PJR, Braid B: Factors affecting plasma levels of lidocaine and prilocaine. Br J Anaesth 67:1040, 1972
8. Replogle K, Reader A, Nist R, et al: Cardiovascular effects of intraosseous injections of 2 percent lidocaine with 1:100000 epinephine and 3 percent mepivacaine. J Am Dent Assoc 130:649, 1999
9. Aitkenhead RA: Local anaesthetic agents, in Aitkenhead RA, Smith G (ed): Textbook of Anaesthesia. New York, NY, Churchill Livingstone,1996, p 236
10. Tesseromatis C, Fichtl B, Kurz H: Binding of non-seroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro. Eur J Drug Metab Pharmacokinet 12:161, 1987
11. Insel P: Analgesic-antipyretics and anti-inflammatory agents, in Goodman-Gilman A (ed): The Pharmacological Basis of Therapeutics. New York, NY, Pergamon Press, 1990, p 657
12. Laurence DR: Inflammation, arthritis and NSAIDs, in Laurence DR (ed): Clinical Pharmacology. New York, NY, Churchill Livingstone, 1997, p 250
13. Feierman DE: The effect of paracetamol on fentanyl metabolism in vitro. Acta Anaesth Scand 44:560, 2000
14. Tran A, Treluyer JM, Rey E, et al: Protective effect of stiripentol on acetaminophen-induced hepatotoxicity. Toxicol Appl Pharmacol 170:145, 2001
15. Kleinman W: Regional anesthesia and pain management, in Morgan EG (ed): Clinical Anesthesiology. New York, NY, Lange, 2002, p 253
16. Cassuto J, Wallin G, Hogstrom S: Inhibition of postoperative pain by continous low dose intravenous infusion of lidocaine. Anesth Analg 19:18, 1985
17. DiFazio CA, Niederlehner JR, Burney RG: The anesthetic potency of lidocaine in the rat. Anesth Analg 55:818, 1976
18. Larson CP: Laryngospasm-the best treatment. Anesthesiology 89:1293, 1998
19. Hoffman MJ, Haug RH, Shepard LS, et al: Care of the asthmatic patient in oral and maxillofacial surgery. J Oral Maxillofac Surg 49:69, 1991
20. Imaoka S, Enomoto K, Oda Y, et al: Lidocaine metabolism by human cyt-P450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P450s. J Pharm Exp Ther 25:1385, 1990
21. Murdoch J, Ritchie N, Greene M: Local anaesthetics, in Goodman-Gilman A (ed): The Pharmacological Basis of Therapeutics. New York, NY, Pergamon Press, 1990, p 320
22. Opie HL, Yusuf S: Beta-blocking agents, in Opie HL, Gersh JB (eds): Drugs for the Heart. Philadelphia, PA, Saunders, 2001, p 31
23. Bode W, Toet AE, Stolker AA, et al: Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat. Chirality 7:626, 1995
24. Stoetling KR: Local anesthetics, in Stoetling KR (ed): Pharmacology and Physiology in Anesthetic Practice. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, p 168
25. Nies AS, Evans GH, Shaud DG: Regional hemodynamic effect of beta adrenergic blockade with propranolol in the unanesthetized primate. Am Heart J 85:97, 1973
26. Hein L, Kobilka BK: Adrenergic receptor signal transduction and regulation. Neuropharmacology 34:357, 1995
27. Masubuchi Y, Umeda S, Igarashi S, et al: Participation of the CYP-2D subfamily in lidocaine 3-hydroxylation and formation of a reactive metabolite covalently bound to liver microsomal protein in rats. Biochem Pharmacol 17:1867, 1993
28. Ochs HR, Carstens G, Greenblatt DJ: Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med 14:373, 1980
29. Hansten DP: Lidocaine interactions, in Hansten DP (ed): Drug Interactions. Philadelphia, PA, Lea & Febiger, 1985, p 8
30. Tesseromatis C, Trichilis A, Saranteas T: Effect of stress on lidocaine levels in serum and tissues in rats. N S Arch Pharm 34:19, 1994 (suppl 2)